Glycoscoredx Limited

#12766216 • Active

GlycoScoreDx Limited is a UK-based diagnostics company focused on revolutionizing prostate cancer diagnosis through a novel blood test that enables accurate early detection of aggressive prostate cancer.

Founded: 24 Jul 2020
Industries:
20590 - Manufacture of other chemical products n.e.c.46180 - Agents specialized in the sale of other particular products72110 - Research and experimental development on biotechnology86900 - Other human health activities
Website: glycoscoredx.co.uk
Email: info@glycoscoredx.co.uk
Location: Newcastle Upon Tyne

Products & Services

• biomarkers
• blood test
• diagnostics
• glycoscore prostate cancer test
• health care
• prostate cancer
• prostate cancer diagnostic testing

Financial Snapshot

Last accounts made up to 31 Jul 2024
Next accounts due 30 Apr 2026 (1 months)
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →
See Full Financials →

People

Officers
3
Shareholders
13
Controllers (PSC)
2
Allan Brown
Director • British • Lives in England • Born in May 1961
Jennifer Munkley
Director • British • Lives in United Kingdom • Born in Aug 1983
Matthew Leslie Pearce
Director • British • Lives in England • Born in Feb 1971
See Key People →

Registered Office Address

Sandgate House

102 Quayside

Newcastle Upon Tyne

NE1 3DX

United Kingdom

View on Map →

Basic Information

LTD
24 Jul 2020
ENGLAND WALES
Yes

Industry Classification

20590, 46180, 72110, 86900

Company Attributes

N/A
N/A
N/A
N/A

Summary

5
Officers
2
PSCs
0
Filings